Absorbent Column, Particles Or Resin Strip Patents (Class 436/541)
-
Patent number: 4757024Abstract: The use of immunologically non-specific peptide linked amino acids containing compounds that are capable of immobilizing circulating immune complexes for the purpose of detection or removal from serum or blood, such compounds including oligopeptides, modified oligopeptides, polypeptides, modified polypeptides, proteins, modified proteins, and in particular glycosylated polypeptides and proteins.Type: GrantFiled: August 8, 1985Date of Patent: July 12, 1988Assignee: Biostar Medical Products, Inc.Inventor: Michael D. Roper
-
Patent number: 4757003Abstract: A process for the detection of cancer comprises an immunological assay of a glycolipid present in blood, thoracic cavity fluid, abdominal dropsy or urine wherein the glycolipid can be any one selected from the group consisting of:(1) asialo GM.sub.1 : galactosyl-N-acetylgalactosaminyl-galactosyl-glucosyl-ceramide;(2) asialo GM.sub.2 : N-acetylgalactosaminyl-galactosyl-glucosyl-ceramide;(3) fuco GA.sub.1 : fucosyl-galactosyl-N-acetylgalactosaminyl-galactosyl-glucosyl-ceramide; and(4) paragloboside: galactosyl-N-acetylglucosaminyl-galactosyl-glucosyl-ceramide.These glycolipids have been found to increase in body fluids with a proliferation of cancer cells.Type: GrantFiled: May 8, 1986Date of Patent: July 12, 1988Assignee: Dainabot Co., Ltd.Inventors: Makoto Matsumoto, Takao Taki, Kenji Arai, Hidemi Ishikawa, Kunio Kurata, Kiyoshi Sekiguchi, Akio Myoga, Kimimichi Obata
-
Patent number: 4752638Abstract: Conjugate monomers, polymers, and methods for the de novo synthesis of the polymers are provided. Conjugate organic monomers contain binding-pair members which upon polymerization become integrally associated with the resultant polymer. Specifically, antigens, antibodies, receptors, and ligands may be bound to organic monomers either directly by chemical reaction or indirectly by chemical spacer arms, and these conjugates may be polymerized or copolymerized with nonderivatized monomers to form polymers containing variable amounts of the binding-pair members. Such conjugate monomers and polymers find a wide variety of uses in binding to their binding-pair-member cognate which include selective removal of complementary binding-pair members from solution as well as in immunoassay procedures and in immunization regimes.Type: GrantFiled: June 30, 1986Date of Patent: June 21, 1988Assignee: Genetic Systems CorporationInventors: Robert C. Nowinski, Allan S. Hoffman, Raymond L. Houghton, John H. Priest, Nobuo Monji
-
Patent number: 4752562Abstract: Disclosed is a method for detection for serum antibody and/or microbial surface antigen by radial partition immunoassay. The method of this invention is applicable to (a) the evaluation of a clinical specimen for identification of a microorganism; (b) antimicrobial sensitivity assays for determination of an efficacious antibiotic for use against a specific microorganism; (c) a semi-quantitative determination of viral surface antigen; and, (d) a quantitative method for the determination of the presence of serum antibodies to microbial antigens. In each of the foregoing applications, the analyte of interest can be immobilized within a porous matrix (solid phase) by simple pipetting of the sample onto the prepared matrix. Appropriate reagents are subsequently applied to the matrix to effect immunochemical interaction of a labeled binding material to the surface antigen (or antibody) of the analyte of interest. The portion of the matrix within which such interaction takes place is termed the "reaction zone".Type: GrantFiled: October 17, 1984Date of Patent: June 21, 1988Assignee: Baxter Travenol Laboratories, Inc.Inventors: Mark I. Sheiman, Joseph L. Giegel, Mary Brotherton
-
Patent number: 4745073Abstract: A cap for a container in which immunoassays are performed includes a liquid absorbing material accessible to liquid in the container.Type: GrantFiled: June 7, 1983Date of Patent: May 17, 1988Assignee: Serono Diagnostics Ltd.Inventors: Gordon Forrest, John F. Stivala
-
Patent number: 4742159Abstract: The present invention provides a process for the preparation of digitalis antibodies in which appropriate mammals are immunized with a digoxin bound to protein, the animal serum is obtained, the immune globulin-containing protein fraction is separated in known manner, the immunologically-active globulins are adsorbed on an immunologically-active column and separated from the other proteins, the antibodies are again eluted from the column and the Fab fractions are split with papain and purified, wherein, as immunologically-active adsorbent, there is used an inorganic matrix of large surface area to which digitoxin aldehyde is bound via a spacer which cannot be split with papain and the splitting off of the Fab fraction from the antibodies is carried out on the matrix.The present invention also provides digitalis antibodies obtained by this process, which antibodies can be used for the therapy of digitalis intoxications and for preparing immunological reagents for the determination of digitalis glycosides.Type: GrantFiled: December 19, 1983Date of Patent: May 3, 1988Assignee: Boehringer Mannheim GmbHInventors: Hans-Georg Batz, Herbert Jungfer, Helmut Lenz, Albert Roder
-
Patent number: 4708932Abstract: An improved process of performing analysis methods based upon biospecific affinity reactions in heterogeneous systems, wherein a ligand dissolved in a liquid is reacted with a receptor immobilized on a carrier, characterized by utilizing as the carrier a porous matrix in the form of a material body having an open capillary pore system capable of absorbing and retaining liquid phase and having such limited void dimensions that the total reaction rate of the biospecific reaction or reactions within the pore system between ligand and immobilized receptor will be at least substantially independent of the diffusion of the ligand in the liquid phase. A porous matrix for use in said process has the characteristics mentioned above.Type: GrantFiled: September 28, 1984Date of Patent: November 24, 1987Assignee: Pharmacia ABInventors: Rolf E. Axen, Goran L. Kaj, Rune Bjorkman
-
Patent number: 4687733Abstract: The invention relates to a method of testing for the presence of cancer. An antibody is produced which contains antibodies specific to a modified nucleoside component. The antibody is admixed with a body fluid drawn from a subject mammal. An immunoassay is performed on the admixture to quantify an amount of cancer associated nucleoside present in the fluid and reactive with the antibody.Type: GrantFiled: January 30, 1984Date of Patent: August 18, 1987Assignee: Ohio State UniversityInventors: Ronald W. Trewyn, Steven M. D'Ambrosio
-
Patent number: 4683197Abstract: A method for the detection of occult human blood in human stool samples by immunologically determining after performing the known peroxidase procedure, a human component abnormally present in the stool.Type: GrantFiled: May 6, 1985Date of Patent: July 28, 1987Assignee: Hoffmann-La Roche Inc.Inventor: Harald Gallati
-
Patent number: 4666866Abstract: Assay for a hapten or antigen wherein supported hapten or antigen is used to separate "bound" and "free" fractions. The sensitivity of the assay is increased.Type: GrantFiled: April 19, 1983Date of Patent: May 19, 1987Inventor: Gary H. Krauth
-
Patent number: 4666865Abstract: Rapid, sensitive and accurate immunoassays for biologically active natural or recombinant human interferon-gamma (huIFN-gamma) based upon monoclonal antibodies which react specifically with epitopes of the biologically active form of huIFN-gamma are disclosed. The immunoassays include sandwich immunoradiometric assay of the forward, reverse or simultaneous type and competitive binding assay such as radioimmunoassay. The assays are also useful for the detection of macrophage activation factor now believed to be identical to huIFN-gamma. In addition, methods of purification of huIFN-gamma employing the monoclonal antibodies are described.Type: GrantFiled: January 13, 1984Date of Patent: May 19, 1987Assignee: Centocor, Inc.Inventors: Tse W. Chang, Patrick C. Kung, Junming Le, Victor Liu, Jan Vilcek
-
Patent number: 4666863Abstract: A method of performing an assay for an analyte comprises providing a chromatographic medium, preferably in sheet form, forming a reaction mixture containing a labelled reagent present partly in a form which is mobile on the medium and partly in a form which is immobile, the proportions of the two forms being related to the analyte concentration, applying the mixture to a spot on the chromatographic medium, optionally applying a solvent to cause the mobile form of the labelled reagent to migrate from the spot, and measuring the label intensity remaining at the spot. The method provides a convenient way of performing immunoassays, 2-site immunometric assays, and agglutination assays.Type: GrantFiled: February 22, 1984Date of Patent: May 19, 1987Assignee: Amersham International plc.Inventors: John C. Edwards, Gerald J. Allen, John K. Martin, Malcolm R. Summers
-
Patent number: 4645747Abstract: The present invention relates to a simple and accurate method to be applied in immunoassay technique for separating the free ligand from the antibody-bound ligand.The method involves the use of a solvent extraction operation which at equilibrium provides the formation of two distinct phases the free- and bound-fraction. The solvent to be utilized should be slightly water miscible or completely water immiscible, having the property of marked selective extraction power toward the gamma-labelled constituent to be determined. The method is applicable in a liquid-liquid system, a solid-liquid system and solid-solid system.The method is useful for radioimmunoassay, free radical assay or metallo-immunoassay, being most versatile having also the advantage that as a result of the free ligand being extracted into the solvent, the determination of the quantity of gamma-labelled substance in the free and/or bound fraction compares very favorably with the known prior art methods in immunoassays.Type: GrantFiled: February 28, 1983Date of Patent: February 24, 1987Assignee: Technion Research & Development Foundation, Ltd.Inventors: Michael Cais, Moshe Shimoni, Abraham Baniel
-
Patent number: 4629689Abstract: At the conclusion of a selective binding assay (e.g., immunological or nucleic acid), an enzyme is present in modulated concentration and/or activity to moderate a chemical reaction such as the cleavage of o-nitrophenyl-.beta.-D-galactopyranoside. After a controlled period, the enzymatic product is transferred to the gas phase and concentrated relative to other components in the enzymatic reaction mixture, such as by extraction into ethyl ether, injection into a gas chromatography column and detection by flame ionization or electron capture. Kits for such assays are also disclosed.Type: GrantFiled: August 29, 1984Date of Patent: December 16, 1986Assignee: Allied CorporationInventors: Steven E. Diamond, Francis J. Regina
-
Patent number: 4628037Abstract: A process is provided for the preparation of magnetic particles to which a wide variety of molecules may be coupled. The magnetic particles can be dispersed in aqueous media without rapid settling and conveniently reclaimed from media with a magnetic field. Preferred particles do not become magnetic after application of a magnetic field and can be redispersed and reused. The magnetic particles are useful in biological systems involving separations.Type: GrantFiled: June 13, 1985Date of Patent: December 9, 1986Assignee: Advanced Magnetics, Inc.Inventors: Mark S. Chagnon, Ernest V. Groman, Lee Josephson, Roy A. Whitehead
-
Patent number: 4609707Abstract: A method is disclosed for the de novo synthesis of antibody-containing polymers and the preparation of a class of polymerizable compounds used in the synthesis of such antibody-containing polymers. Antibody-containing polymers formed from monomer/antibody conjugates and nonderivatized polymerizable compounds can be varied in formation of the polymer to provide control of (a) molecular spacing, steric accessibility and the number of antibody molecules that are integrally incorporated into the polymer backbone, and (b) the chemical and physical structure of the polymer itself, thus enabling specific tailoring of antibody-containing polymers for particular end-use application. Also disclosed is a method for the selective removal of a compound from a solution or suspension thereof using monomer/receptor conjugates where the compound has the capacity to bind to the receptor in the conjugate.Type: GrantFiled: November 7, 1984Date of Patent: September 2, 1986Assignee: Genetic Systems CorporationInventors: Robert C. Nowinski, Allan S. Hoffman
-
Patent number: 4594327Abstract: Methods and compositions are provided for performing an assay on whole blood samples. The method is for a determination of an analyte which is a member of a specific binding pair (sbp) consisting of ligand and homologous receptor. The method involves a binding agent for the red blood cells in such sample, a solid bibulous element to which is bound at least one sbp member, and a signal-producing system. The method comprises combining the whole blood sample, the binding agent, and none or, where appropriate, one or more members of the signal producing system. The medium is next contacted with a portion of a solid bibulous element to which is bound one of the members of the specific binding pair to allow the medium to traverse such element (immunochromatography). The solid bibulous element is contacted with any remaining members of the signal producing system. Signal resulting from the signal producing system is detected and is related to the amount of the analyte in the sample.Type: GrantFiled: November 2, 1983Date of Patent: June 10, 1986Assignee: Syntex (U.S.A.) Inc.Inventor: Robert F. Zuk
-
Patent number: 4560647Abstract: A method for the determination of antigens or antibodies in a fluid by incubation of particles, which have antigens on the surface, and antibodies, whereby either the antigens or the antibodies are of known specificity is described. This method comprises introducing the antigen/antibody complex into a container having a conical-shaped or keel-shaped bottom recess, whereby at least the recess of the container is coated with an immunoglobulin-building component which is directed against the antibodies. After centrifugation the amount of the sediment is determined, which indicates whether the antigen or antibody to be determined is present or not.Type: GrantFiled: January 30, 1984Date of Patent: December 24, 1985Assignee: Hoffmann-La Roche Inc.Inventor: John Stocker
-
Patent number: 4552839Abstract: Methods and compositions are provided for concentrating particles in a minute area on a solid surface. The method permits the detection of small amounts of analytes by providing for an observable signal in relation to the concentration of particles in the area.Type: GrantFiled: August 1, 1983Date of Patent: November 12, 1985Assignee: Syntex (U.S.A.) Inc.Inventors: Dennis R. Gould, Robert F. Zuk
-
Patent number: 4551426Abstract: A heterogeneous immunoassay for digoxin. An excess of labeled anti-digoxin antibody is added to a test sample and the resulting reaction mixture is contacted with a solid phase having ouabain immobilized thereon. All the free, labeled antibody binds to the oubain. The eluted digoxin anti-digoxin antibody complex is measured for label activity. A competitive mode is also disclosed.Type: GrantFiled: January 18, 1984Date of Patent: November 5, 1985Assignee: E. I. Du Pont de Nemours and CompanyInventors: William J. Freytag, Shung-Ho Chang
-
Patent number: 4551435Abstract: A process and apparatus for removing immuno-specifically recognizable substances in the form of immune complexes from a solution. The solution containing preformed immune complexes or immune complexes already present therein is contacted with an adsorbent consisting of non-immunospecific factor such as Clq, rheumatoid factor, Fc receptor and Fc receptor-bearing cells.Type: GrantFiled: August 24, 1983Date of Patent: November 5, 1985Assignee: Immunicon, Inc.Inventors: Paul A. Liberti, Paul Pollara
-
Patent number: 4550085Abstract: Histamine is detected or determined selectively in a sample by causing the sample to contact glass microfibers in such a quantitative proportion as will permit the histamine present to bind to the fibers. The amount of bound histamine may be determined by competitive determination in the presence of labelled histamine on the basis of a standard curve, or may be determined directly by conventional coupling reactions.The method is simple and particularly useful for allergy diagnostics because it exhibits good correlation with known fluorometric methods.Type: GrantFiled: September 8, 1981Date of Patent: October 29, 1985Inventors: Per S. Skov, Svend Norn, Bent Weeke
-
Patent number: 4543439Abstract: A hybridoma cell line is disclosed that secretes monoclonal antibodies which serve as a high titer, reproducible, biological reagent useful in biological/medical research for isolating and identifying phosphotyrosine-containing proteins. In addition, the antibodies have potential uses in diagnosis of a variety of diseases, including certain cancers. The antibodies, which have demonstrated affinity for a variety of molecules containing o-phosphotyrosine residues, were prepared using a synthetic analog, p-azobenzyl phosphonate (ABP) covalently linked to a carrier protein, as the antigen.Type: GrantFiled: December 13, 1982Date of Patent: September 24, 1985Assignee: Massachusetts Institute of TechnologyInventors: A. Raymond Frackelton, Jr., Herman N. Eisen, Alonzo H. Ross
-
Patent number: 4522923Abstract: The present invention describes an apparatus and method for conducting immunochemical reactions in a self-contained sealed unit that requires only the addition of an unknown sample and water. The apparatus comprises a test tube with at least three chambers each containing different chemicals, including a solid sphere, and separated from each other by a water-soluble barrier.Type: GrantFiled: October 3, 1983Date of Patent: June 11, 1985Assignee: Genetic Diagnostics CorporationInventors: Alice Deutsch, Herbert Platt
-
Patent number: 4517288Abstract: A method for conducting a ligand assay in an inert porous medium wherein a binding material is immunologically immobilized within the medium, which includes the steps of immunologically immobilizing a binding material within a finite zone of the medium, applying an analyte to the zone containing the immobilized binding material, applying a labeled indicator to the zone which becomes immobilized within the zone in an amount which can be correlated to the amount of analyte in the zone, applying a solvent to substantially the center of the zone to chromatographically separate the unbound labeled indicator from the zone, and measuring the amount of labeled indicator remaining in the zone.Type: GrantFiled: January 23, 1981Date of Patent: May 14, 1985Assignee: American Hospital Supply Corp.Inventors: Joseph L. Giegel, Mary M. Brotherton
-
Patent number: 4517303Abstract: A novel analyte-cytolysin conjugate and its use in a lipid vesicle mediated measurement process is described for a wide variety of analytes present at very low concentration. The method involves forming a reaction system consisting of analyte, analyte specific binding agent, analyte-cytolysin conjugate, and vesicles containing detectable marker material in such proportions that uncombined conjugate alters the permeability of the vesicles resulting in the release and quantitative detection of marker material which can be correlated with the amount of analyte initially present.Type: GrantFiled: October 20, 1982Date of Patent: May 14, 1985Assignee: E. I. Du Pont de Nemours and CompanyInventors: J. William Freytag, William J. Litchfield
-
Patent number: 4511478Abstract: A method is disclosed for the de novo synthesis of polypeptide-containing polymers. This disclosure also includes a description of, and a method for the preparation of, a class of polymerizable compounds used in the synthesis of polypeptide-containing polymers. These polymerizable compounds are chemical conjugates prepared by covalent linkage of polymerizable organic monomers with specific polypeptides. Soluble monomer/polypeptide conjugates can be polymerized in solution with additional nonderivatized organic monomers to form desired polypeptide-containing polymers. The amount and composition of monomer and monomer/polypeptide conjugates can be varied in order to provide control of (a) molecular spacing, steric accessibility, and number of polypeptide molecules that are integrally incorporated into the polymer backbone, and (b) the chemical and physical structure of the polymer itself. This enables the specific tailoring of polypeptide-containing polymers for particular end-use applications.Type: GrantFiled: November 10, 1983Date of Patent: April 16, 1985Assignee: Genetic Systems CorporationInventors: Robert C. Nowinski, Allan S. Hoffman
-
Patent number: 4506009Abstract: A conjugate useful in determining the amount of antigen or antibody in a liquid sample, said conjugate having a marker, an immunoreactive component (i.e. antigen or antibody) bound to the marker and an insolubilizing binding component which is also bound to the marker. The insolubilizing binding component portion of the conjugate will react with an insolubilizing receptor to form a solid product of conjugate and receptor unless the conjugate reacts with the corresponding antigen or antibody to be analyzed in which event the conjugate will not react with the insolubilizing receptor. The conjugate will be added to a liquid sample containing an unknown amount of, for example, an antibody. A known amount of the corresponding antigen is also added which reacts with both the conjugate and antibody. After the reaction is complete, the liquid sample is contacted with the insolubilizing receptor.Type: GrantFiled: March 30, 1982Date of Patent: March 19, 1985Assignee: University of CaliforniaInventors: Howard M. Lenhoff, That T. Ngo
-
Patent number: 4504587Abstract: The antigens procollagen peptide (type (III) and procollagen peptide col 1 (type III) can be determined together immunologically by either(a) reacting a specified amount in each case of labeled procollagen peptide (type III) or procollagen peptide col 1 (type III) and a highly specific antiserum containing antibodies having affinity for both the antigens mentioned together with a sample having an unknown content of procollagen peptide (type III) and/or procollagen peptide col 1 (type III), separating off the antigen-antibody complex formed and measuring the amount of labeling in the complex and/or in the supernatant, or(b) bringing a specified amount of the highly specific antiserum to reaction with a sample having an unknown content of procollagen peptide (type III) and/or procollagen peptide col 1 (type III), fixing the unreacted amount of the antibody to procollagen peptide (type III) or procollagen peptide col 1 (type III) bound to a support, and bringing to reaction with a labeled second antibody, and thType: GrantFiled: March 11, 1983Date of Patent: March 12, 1985Assignee: Hoechst AktiengesellschaftInventors: Rupert Timpl, Dietrich Brocks, Horst Neubauer, Helmut Strecker
-
Patent number: 4487839Abstract: Methods for determining the presence of antigens or antibodies in an aqueous sample or presence of antigens on the surface of cells. A preferred embodiment employs fluorescent antigens which compete with the sample antigens for antibody binding sites. The antibodies are deposited on a support surface means in alternating patterns. The surface means and fluorescence detector are translocated with respect to each other and a signal generated by the detection of the repeating pattern of fluorescence. The signal is analyzed by means of a gated integrator responsive to a gate track control means also located on the surface means. Immunoassay methods having increased sensitivity are thereby obtained.Type: GrantFiled: January 5, 1983Date of Patent: December 11, 1984Assignee: Ortho Diagnostic Systems Inc.Inventor: Louis A. Kamentsky
-
Patent number: 4478945Abstract: Clinical method for evaulating thyrometabolic function by determination of clinically important thyroxine concentrations and thyroxine binding protein capacities in plasma.The method employs a competitive binding technique for determining free thyroxine concentration and thyroxine binding capacity for plasma having a known total thyroxine concentration.Type: GrantFiled: July 28, 1981Date of Patent: October 23, 1984Inventors: Wai-Nang P. Lee, Michael D. Harpen, Jeffry A. Siegel
-
Patent number: 4473652Abstract: A method for immunochemical assay of an antigen or antibody by labelling the antigen or antibody with a specific cyanine or merocyanine dye containing a carboxy group followed by effecting an immune reaction and photochemical processing thereof is provided. The amount of the antigen or antibody is measured in term of optical density of developed silver halide which is brought into contact with either the antigen-antibody reaction product or the unreacted material.This immunochemical assay method gives high detection sensitivity in a simple operation manner.Type: GrantFiled: June 22, 1983Date of Patent: September 25, 1984Assignee: Fuji Photo Film Co., Ltd.Inventors: Masaki Okazaki, Nobuhito Masuda, Yoshiro Kumano
-
Patent number: 4469796Abstract: An improvement in assaying methods involving biospecific affinity reactions, in which there are used from 2 to 4 reactants, one of which, reactant (I), is labelled with at least one analytically indicatable atom or group and is soluble in the aqueous liquid in which the biospecific affinity reaction is carried out, the reactants forming, by means of biospecific reactions, a conjugate in which labelled reactant (I) is incorporated; and in which assaying methods the analytically indicatable atom or group is assayed in the conjugate and/or in labelled reactant (I), which is not bound to the conjugate. The conjugate that has been formed or labelled reactant (I) not bound to the conjugate is bound covalently to an insoluble carrier or to an insolubilizable carrier, which latter carrier is made insoluble after the covalent binding has been carried out, whereafter the assay of the analytically indicatable atom or group is carried out.Type: GrantFiled: May 5, 1981Date of Patent: September 4, 1984Assignee: Pharmacia Diagnostics ABInventors: Rolf E. A. V. Axen, Sven O. H. Oscarsson, Per H. G. Ponterius, Jan P. E. Carlsson
-
Patent number: 4459361Abstract: Method of making and using products for analysis of specific ligands in solution. More specifically, a method of analyzing a sample for a ligand by incubating the sample with a ligand selective binder and with a predetermined amount of ligand, the binder and/or the predetermined amount of ligand being borne by particles of predetermined size, filtering the solution and analyzing the particles which pass through the filter and/or those particles that do not pass through the filter.Type: GrantFiled: June 4, 1982Date of Patent: July 10, 1984Assignee: Angenics, Inc.Inventor: Malcolm L. Gefter
-
Patent number: 4456689Abstract: An improved competitive protein binding assay comprising; incubating an analyte in the presence of labeled analyte and a protein binder suitable for competitive binding activity by the analyte and the labeled analyte to provide a mixture having free analyte, free labeled analyte, bound analyte and bound labeled analyte, substantially separating the bound analyte and the bound labeled analyte from the free analyte and free labeled analyte to form a first fraction containing substantially the bound analyte and the bound labeled analyte and a second fraction containing substantially the free analyte and the free labeled analyte by causing a predetermined level of the mixture to flow through a bed of an organo-silane coupled to silica gel, and detecting the labeled analyte of at least one of the first and second fractions to determine the concentration of the analyte by comparison to a reference.Type: GrantFiled: May 17, 1982Date of Patent: June 26, 1984Assignee: Becton Dickinson and CompanyInventors: Thomas R. Witty, Mark E. Astill
-
Patent number: 4456690Abstract: The present invention relates to a method which eliminates centrifugation and decantation steps, to be performed in an automatic manner for carrying out specific binding assay tests, wherein liquid and solid phases are present.According to the invention, use is made of a specially designed device, consisting of a mixing reservoir into which is fitted snugly a mixer separator having a channel in the vertical axis of the mixer-separator. A rack holding a number of said mixing reservoirs containing the incubated reagents and analytes, capped with the mixer separators, is placed into a press-device designed to perform at a controlled rate a downward movement. The mixer separators are pushed downwards into the mixing reservoirs at a chosen rate for a preselected distance to complete the mass transport and separation operations. The separation devices are removed and either one of the separated phases can be measured in the desired analytical instrument for a quantitative or qualitative determination.Type: GrantFiled: June 29, 1982Date of Patent: June 26, 1984Assignee: Technion Research and Development Foundation, Ltd.Inventors: Michael Cais, Moshe Shimoni
-
Patent number: 4435504Abstract: Chromatographic immunoassay employing a specific binding pair member and a label conjugate which delineates a border whose distance from one end of the chromatograph relates to the amount of analyte present. By combining the label conjugate and sample in a solution and immunochromatographing the solution, or employing a combination of enzymes, one enzyme being the label and the other enzyme affixed to the chromatographic support, the position of the border defined by the label can be related to the amount of analyte in the sample solution.Preferably, an immunochromatograph is employed having both a specific binding pair member and an enzyme affixed to the support.Type: GrantFiled: July 15, 1982Date of Patent: March 6, 1984Assignee: Syva CompanyInventors: Robert F. Zuk, David J. Litman
-
Patent number: 4434236Abstract: A method for the rapid determination of analyte in a sample is provided. The sample is contacted with a solid phase having immobilized thereon an analyte-analogue to which there is displaceably bound a labeled anti-analyte antibody. Because the antibody has greater affinity for the analyte than the analyte-analogue, the labeled antibody is displaced from the solid phase. The complex is separated from the solid phase, and the amount of complex is measured. The measured amount is related to the amount of analyte initially present in the sample.Type: GrantFiled: October 20, 1982Date of Patent: February 28, 1984Assignee: E. I. Du Pont de Nemours & Co.Inventor: J. William Freytag
-
Patent number: 4429050Abstract: A method for the simultaneous immunochemical assay of trace components in a sample involving competitively reacting the antigens or antibodies in a sample and labeled antigens or labeled antibodies for limited binding sites. The labels are spectral sensitizing dyes. The reaction products are contacted with silver halide and exposed to light having wavelengths corresponding to the absorption spectra of the spectral sensitizing dyes.Type: GrantFiled: September 2, 1981Date of Patent: January 31, 1984Assignee: Fuji Photo Film Co., Ltd.Inventors: Yukio Yasuda, Nobuhito Masuda, Yuji Mihara, Masaki Okazaki, Nobuo Hiratsuka
-
Patent number: 4425438Abstract: A method and device for assaying a test substance utilizing a primary absorbent substance for selectively allowing only a quantity of an analytical reagent proportional to the quantity of test substance to pass therethrough when test substance and analytical reagent are contacted with the primary absorbent. An analytical absorbent is disposed in a series of zones for sequentially absorbing the analytical reagent which passes through the primary absorbent so that detection of the last zone of absorbed analytical reagent indicates the quantity of test substance. The method comprises passing test substance and analytical reagent through the primary absorbent and then the analytical absorbent followed by detection of the last zone in which analytical reagent is absorbed. The device comprises a funnel with the primary absorbent therein for directing the test substance and analytical reagent to a narrow tube holding the analytical absorbent.Type: GrantFiled: March 13, 1981Date of Patent: January 10, 1984Inventors: David S. Bauman, Paul A. Barstad
-
Patent number: 4387166Abstract: The sensitivity of hemagglutination inhibition tests is improved by introducing a determined amount of lyophilized antigen or antibody into serological tubes in the absence of the indicator component. The test fluid to be analyzed is incubated solely in the presence of its binding partner in a liquid phase. After completion of the binding reaction (about 5 hours but extendable to 18 hours), the sensitized indicator solid phase, usually consisting of sensitized red blood cells, is added. By this process a 10 to 20 fold increase in sensitivity of the hemagglutination inhibition test is routinely achieved.Type: GrantFiled: September 15, 1981Date of Patent: June 7, 1983Assignee: Anda BiologicalsInventor: Roland F. Maes
-
Patent number: 4387086Abstract: The invention relates to an antiserum suitable for the determination of thioridazine in blood, blood plasma and urine, the use of the antiserum and a process of determining thioridazine in blood, blood plasma or urine with the aid of this specific antiserum.Type: GrantFiled: September 8, 1980Date of Patent: June 7, 1983Assignee: Sandoz Ltd.Inventor: Joachim Rosenthaler
-
Patent number: RE32098Abstract: This invention relates to a highly accurate, rapid and simple estimation of thyroxine (T.sub.4) directly from blood serum and also relates to the accurate measurement of triiodo-L-thyronine (T.sub.3) directly from blood serum. More specifically, the invention relates to a rapid, specific and reliable radioimmunoassay (RIA) technique for measurement of both T.sub.4 and T.sub.3 in unextracted serum. The method requires very small amounts of serum, e.g., 25 microliters (.mu.l) to measure T.sub.4 concentration in nearly all specimens representing clinical states of eu-, hypo- and hyperthyroidism, and 250 .mu.l to measure T.sub.3 concentrations in specimens representing most clinical states.Type: GrantFiled: August 10, 1978Date of Patent: March 25, 1986Assignee: Research and Education Institute, Inc.Inventor: Inder J. Chopra
-
Patent number: RE32557Abstract: A method is provided for determining the concentration of pregnanediol glucuronide (PG) in a woman's urine which is characterized by utilization of the reagent 20.alpha.-hydroxy-4-pregnen-3-one (20-.alpha. reagent) in a form in which it reacts with antibodies binding to PG. The method is adaptable to a visual color indication test which can be performed by the woman herself as well as by laboratory analysis. The method can be used to define the period in which conception can occur, to define a post-ovulation safe period in which conception is prevented, and as an early pregnancy indicator.Type: GrantFiled: February 27, 1986Date of Patent: December 8, 1987Assignee: Northwestern UniversityInventor: Robert T. Chatterton